News

Spectral AI Begins Enrollment in Pivotal Study to Validate DeepView AI® for Burn Injuries

DALLAS, Jan. 11, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASD:MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI)…

2 years ago

TransCode Therapeutics Announces 1-for-40 Reverse Stock Split

BOSTON, Jan. 11, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ) (“TransCode” or the “Company”), the RNA Oncology Company™…

2 years ago

Alira Health and Sancare Join Forces to Drive Healthcare Innovation in France

FRAMINGHAM, Mass., Jan. 11, 2024 (GLOBE NEWSWIRE) -- Alira Health, a global advisory and clinical research firm, and Sancare, an…

2 years ago

Emergent BioSolutions Awarded Procurement Contract Valued up to $235.8 Million to Supply BioThrax® (Anthrax Vaccine Adsorbed) to the U.S. Department of Defense

GAITHERSBURG, Md., Jan. 11, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has secured an indefinite-delivery,…

2 years ago

QIAGEN N.V. to release results for Q4 2023 and hold webcast

Venlo, The Netherlands, Jan. 11, 2024 (GLOBE NEWSWIRE) -- QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced plans to…

2 years ago

Praxis Precision Medicines, Inc. Announces Pricing of $150.0 Million Public Offering

BOSTON, Jan. 11, 2024 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights…

2 years ago

The Joint Corp. Reports 2023 Operating Metrics

- Grows Annual System-Wide Sales 12%, Compared to 2022 -- Increases Comp Sales of 4%, Compared to 2022 - -…

2 years ago

New study confirms Smith+Nephew’s REGENETEN™ Bioinductive Implant reduces full-thickness rotator cuff re-tear rates¹ by 68%

REGENETEN Patch 2024 Smith+Nephew's REGENETEN Bioinductive Implant First published randomized controlled trial for market-leading implant demonstrates impressive outcomes for rotator…

2 years ago